Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options

This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms, particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other, including an Interactive Treatment Decision Support Tool, an expert-authored commentary and module, and a downloadable slideset.
Srdan Verstovsek, MD, PhD


In this downloadable slideset, Srdan Verstovsek, MD, PhD, reviews key data informing optimal treatment strategies for MF and PV.

Released: May 8, 2017

In this interactive, CME/CE-certified module, Srdan Verstovsek, MD, PhD, provides expert perspectives on key data informing optimal treatment strategies for MF and PV.

Srdan Verstovsek, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: May 8, 2017 Expired: No longer available for credit
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an educational grant from

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.